Primary structure of the human platelet serotonin 5-HT2A receptor: identity with frontal cortex serotonin 5-HT2Areceptor

Author(s): Cook EH, Fletcher KE, Wainwright M, Marks N, Yan SY, et al.


Previous radioligand binding studies have demonstrated human platelet serotonin2A (5-HT2A) receptor binding sites. Pharmacological similarities between platelet and frontal cortex 5-HT2A receptor binding parameters have been demonstrated. However, it is not clear whether the platelet 5-HT2A receptor primary structure is identical to that of the brain receptor. Three overlapping cDNAs were obtained to span completely the coding region of the 5-HT2A receptor. These clones were sequenced with external and internal primers. The nucleotide sequence of human platelet 5-HT2A cDNA was identical to that reported for the human frontal cortex 5-HT2A receptor, except for nucleotide 102 (T → C), which has been reported to represent a normal DNA polymorphism that does not alter the amino acid sequence. This finding may have implications in the study of neuropsychiatric disorders for which altered platelet 5-HT2A receptor binding has been demonstrated.

Similar Articles

The non-cognitive features of dementia

Author(s): Allen NHP, Burns A

Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Author(s): Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Engchild J, et al.

Protein folding assisted by chaperones

Author(s): Borges JC, Ramos CH

Heat shock protein 70 in Alzheimer's disease

Author(s): Lu RC, Tan MS, Wang H, Xie AM, Yu JT, et al.

BDNF is essential to promote persistence of long-term memory storage

Author(s): Bekinstein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, et al.

BDNF in sleep, insomnia, and sleep deprivation

Author(s): Schmitt K, Holsboer-Trachler E, EC-Kert A

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease

Author(s): Philips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, et al.

The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients

Author(s): Ciaramella A, Salani F, Bizzoni F, Orfei MD, Langella Rangelucci F, et al.

Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?

Author(s): Fahnestock M, Garzon D, Holsinger RM, Michalski B

BDNF and full-length and truncated TrkB expression in Alzheimer disease

Author(s): Ferreer I, Marin C, Rey MJ, Ribalta T, Goutane, et al.

The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease

Author(s): Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, et al.

Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease

Author(s): Nacmias B, Tedde A, Forleo P, Piacentini S, Guamieri BM, et al.